Abstract
Peripheral blood lymphocytes were studied using OKT3, OKT4 and OKT8 monoclonal antibodies in patients with idiopathic thrombocytopenic purpura ITP) before and after high dose gammaglobulin therapy. Total lymphocyte counts increased in 8 of 10 patients studied within 16 weeks of presentation (acute ITP) but decreased in all 6 with chronic (6 months-14 years) thrombocytopenia (P = 0.003). A relative increase in the proportion of inducer-helper (OKT4) cells was seen in 5 of 6 patients with sustained responses whereas there was no clear cut change or a relative increase in suppressor-cytotoxic (OKT8) cells in 7 or 9 with transient responses. The data suggest that short term gammaglobulin therapy may induce sustained responses by immunoregulation of T-lymphocyte subsets.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
